Okla. Admin. Code § 252:100-17-9

Current through Vol. 42, No. 1, September 16, 2024
Section 252:100-17-9 - Definitions

The following words and terms when used in this part shall have the following meaning unless the context clearly indicates otherwise:

"Antineoplastic agents" means drugs used to inhibit and combat the development of neoplasms.

"Biomedical radioactive waste" means low-level radioactive waste as defined in 40 CFR 60.51c.

"Biomedical waste" means medical/infectious waste as defined in 40 CFR 60.51c, Chemotherapeutic waste and biomedical radioactive waste.

"Biomedical waste incinerator" means an incinerator used to burn biomedical waste.

"Chemotherapeutic waste" means waste material resulting from the production or use of antineoplastic agents.

"Neoplasms" means tumors consisting of an abnormal proliferation of cells. The growth of this clone of cells exceeds, and is uncoordinated with, that of the normal tissues around it. Neoplasms may be benign, pre-malignant or malignant.

Okla. Admin. Code § 252:100-17-9

Added at 28 Ok Reg 643, eff 7-1-11